Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bayer AG buy mthimm

Start price
€56.11
05.02.21 / 80%
Target price
€90.00
05.02.22
Performance (%)
-5.54%
End price
€53.00
05.02.22
Summary
This prediction ended on 05.02.22 with a price of €53.00. With a performance of -5.54%, the BUY prediction for Bayer AG by mthimm closed slightly in the red. A total of €2.00 was paid as dividends for this prediction. mthimm has 80% into this prediction

Bayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.

Performance without dividends (%)
Name 1w 1m 1y 3y
Bayer AG -2.266% -2.266% -57.017% -52.311%
iShares Core DAX® -0.870% -1.700% 10.560% 13.129%
iShares Nasdaq 100 -5.561% -3.604% 34.335% 39.856%
iShares Nikkei 225® -6.138% -7.732% 16.215% 0.044%
iShares S&P 500 -3.141% -2.011% 24.534% 39.859%

According to mthimm what are the pros and cons of Bayer AG for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
High dividend yield expected
positive Cash Flow expected
Good rating
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Very capable Management
Very good company culture
Strong uniques
Very differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Medium risks for its business
Cons
Little Investments for future growth
Risky balance sheet
Little innovation

Comments by mthimm for this prediction

In the thread Bayer AG diskutieren
Prediction Buy
Perf. (%) -5.54%
Target price 90.000
Change
Ends at 05.02.22

Monsanto ist nahezu überwunden. In vielen Sparten ist Bayer führend und gehört zu den Topkonzernen im Chemiebereich. Ich erwarte eine positive Konjunkturentwicklung und dadurch überproportional steigende Ergebnisse. Gegenüber dem Markt ist die Bayeraktie unterbewertet, hat daher weiterhin Aufholpotential.

In the thread Trading Bayer AG
Prediction Buy
Perf. (%) -5.54%
Target price 90.000
Change
Ends at 05.02.22

Die von mthimm gewählte maximale Laufzeit wurde überschritten